66203-94-9 Usage
Uses
Used in Cardiology:
Murocainide is used as an antiarrhythmic agent for stabilizing abnormal heart rhythms. It is particularly effective in treating arrhythmias such as atrial fibrillation and ventricular tachycardia, providing a promising therapeutic option for patients suffering from irregular heartbeats.
Used in Pharmaceutical Industry:
Murocainide is used as a key component in the development of medications aimed at managing and treating cardiac arrhythmias. Its ability to block sodium channels in the heart muscle makes it a valuable asset in the creation of drugs that can effectively control irregular heartbeats without causing harm to the heart's normal functioning.
Further research is necessary to explore the full potential of murocainide in clinical practice, ensuring its safety and efficacy for patients with various types of arrhythmias.
Check Digit Verification of cas no
The CAS Registry Mumber 66203-94-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,2,0 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 66203-94:
(7*6)+(6*6)+(5*2)+(4*0)+(3*3)+(2*9)+(1*4)=119
119 % 10 = 9
So 66203-94-9 is a valid CAS Registry Number.
InChI:InChI=1/C19H27N3O5/c1-20-19(23)21-14-15(24-2)13-7-11-26-16(13)18(25-3)17(14)27-12-10-22-8-5-4-6-9-22/h7,11H,4-6,8-10,12H2,1-3H3,(H2,20,21,23)
66203-94-9Relevant articles and documents
Synthesis and Antiarrhythmic Activity of New Benzofuran Derivatives
Bourgery, Guy,Dostert, Philippe,Lacour, Alain,Langlois, Michel,Pourrias, Bernard,Tisne-Versailles, Jacky
, p. 159 - 167 (2007/10/02)
Various 5-aminobenzofuran derivatives were prepared from khellin and screened intravenously in the dog for their potential antiarrhythmic activity against ouabain-induced ventricular arrhythmia and in the Harris test.From systematic structural variations it was found that two methoxy groups in positions 4 and 7 on the benzofuran ring, a tertiary aminoethoxy side chain in position 6, and a N-methylurea group in position 5 led to the most active compounds.These were then tested orally in the Harris test in the dog.The two long-acting derivativesN--N'-methylurea (8j) and N--N'-methylurea (8m) showed advantages when compared to quinidine and diisopyramide and have been selected for further studies.